Related Experiment Video
Updated: Aug 12, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Diagnostic Value of Serum YKL-40 Level for Coronary Artery Disease: A Meta-Analysis
Insights
Elevated serum YKL-40 levels are a promising indicator for diagnosing coronary artery disease (CAD). This meta-analysis confirms higher YKL-40 in CAD patients, suggesting its diagnostic value.
Area of Science:
- Biomarkers and Diagnostics
- Cardiovascular Research
- Medical Research
Background:
- Coronary artery disease (CAD) poses a significant global health challenge.
- Early and accurate diagnosis of CAD is crucial for effective management and improved patient outcomes.
- Identifying reliable diagnostic markers for CAD remains an active area of research.
Purpose of the Study:
- To evaluate the diagnostic value of serum YKL-40 levels in patients with coronary artery disease (CAD).
- To synthesize evidence from multiple studies to determine the association between YKL-40 and CAD.
- To assess the potential of serum YKL-40 as an early diagnostic tool for CAD.
Main Methods:
- A comprehensive meta-analysis was conducted by searching multiple electronic databases, including PubMed, Web of Science, and EMBASE.
- Eleven clinical case-control studies involving 1,175 CAD patients and 1,261 healthy controls were included.
- Statistical analysis was performed using STATA software, calculating standard mean difference (SMD) with 95% confidence intervals (CI).
Main Results:
- The meta-analysis revealed significantly higher serum YKL-40 levels in CAD patients compared to healthy controls (SMD = 2.79, 95% CI = 1.73–3.85, P < 0.001).
- Ethnicity-stratified analyses showed elevated YKL-40 in CAD patients across Chinese, Korean, and Danish populations.
- No significant difference was observed in the Turkish population (SMD = 4.52, 95% CI = -2.87–11.91, P = 0.231).
Conclusions:
- Elevated serum YKL-40 levels show promise as a diagnostic biomarker for coronary artery disease (CAD).
- This finding supports the potential utility of YKL-40 for the early identification of individuals with CAD.
- Further research may validate YKL-40 as a routine diagnostic marker in clinical practice.
Objective:
This meta-analysis aimed to identify the value of serum YKL-40 level for the diagnosis of coronary artery disease (CAD).
Methods:
Through searching the following electronic databases: the Cochrane Library Database (Issue 12, 2013), Web of Science (1945 ∼ 2013), PubMed (1966 ∼ 2013), CINAHL (1982 ∼ 2013), EMBASE (1980 ∼ 2013), and the Chinese Biomedical Database (CBM; 1982 ∼ 2013), related articles were determined without any language restrictions. STATA statistical software (Version 12.0, Stata Corporation, College Station, TX) was chosen to deal with statistical data. Standard mean difference (SMD) and its corresponding 95% confidence interval (95% CI) were calculated.
Results:
Eleven clinical case-control studies that recruited 1,175 CAD patients and 1,261 healthy controls were selected for statistical analysis. The main findings of our meta-analysis showed that serum YKL-40 level in CAD patients was significantly higher than that in control subjects (SMD = 2.79, 95% CI = 1.73 ∼ 3.85, P < 0.001). Ethnicity-stratified analysis indicated a higher serum YKL-40 level in CAD patients than control subjects among China, Korea, and Denmark populations (China: SMD = 2.97, 95% CI = 1.21 ∼ 4.74, P = 0.001; Korea: SMD = 0.66, 95% CI = 0.17 ∼ 1.15, P = 0.008; Denmark: SMD = 1.85, 95% CI = 1.42 ∼ 2.29, P < 0.001; respectively), but not in Turkey (SMD = 4.52, 95% CI = -2.87 ∼ 11.91, P = 0.231).
Conclusion:
The present meta-analysis suggests that an elevated serum YKL-40 level may be used as a promising diagnostic tool for early identification of CAD.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

